Unmet medical need
acterial infections have historically been the cause of high morbidity and mortality among humans. The discovery of penicillin in the late 1920th revolutionized the treatment of infectious diseases.

owever, frequent and widespread use of different types of antibiotics has lead to a situation where emerging and increasing resistance to antibiotics has become a threat to public health all over the world.

  here is a huge unmet medical need for novel antibiotics capable of addressing the problems of bacterial resistance. The requirement of new antibiotics is particularly relevant in the area of Healthcare Associated Infections.

n the US Healthcare Associated Infections contribute to around 100.000 deaths each year. In EU the situation is also more than alarming with approximately 4.1 million patients estimated to acquire a Healthcare Associated Infection every year. The number of deaths occurring as a direct consequence of these infections is estimated to be at least 37 000.

Relevant links:
Antibiotic resistance proportion of different bacterial isolates in Europe

European Centre for Disease Prevention and Control (ECDC)

Centers for Disease Prevention and Control in US

Swedish Institute for Communicable Disease Control (Smittsskyddsinstitutet):